If you have been following health news, you have likely heard about the "legalization" of medical cannabis in the UK. Since 2018, when the law changed to allow doctors to prescribe cannabis-based products for medicinal use, many patients have assumed the National Health Service (NHS)—the UK’s publicly funded healthcare system—would be the primary port of call. Yet, years later, patients are still struggling to find an NHS specialist willing to write a prescription.
I’ve spent the last nine years working within and writing about the NHS. I have seen countless policy changes, but few have been as misunderstood as the status of medical cannabis. It is time to peel back the layers on why this is happening and why the "limited NHS access medical cannabis" narrative is so prevalent.
The 2018 Law: A Significant Shift, but Not a Green Light
In November 2018, the UK government moved cannabis-based products for medicinal use (CBPMs) from Schedule 1 to Schedule 2. This effectively acknowledged that these products have a therapeutic value. However, the legislation was not a blanket invitation for GPs (General Practitioners) to write prescriptions.
The law explicitly stated that only specialist doctors—those listed on the General Medical Council’s specialist register—could initiate a prescription. Even then, the criteria were incredibly narrow. We aren’t talking about general wellness or minor aches. The NHS prescribing guidelines for cannabis are designed for rare, complex conditions where other standard treatments have failed. Think of severe childhood epilepsy, multiple sclerosis-related spasticity, or chemotherapy-induced nausea that doesn’t respond to standard anti-emetics.
Here is what usually happens next:
You visit your GP with the hope of discussing medical cannabis. Your GP looks at the clinical guidance provided by the National Institute for Health and Care Excellence (NICE). They see that for the vast majority of conditions, there is a lack of high-quality evidence to support the routine use of cannabis. They explain that they cannot prescribe it themselves, and they are hesitant to refer you to a specialist who might also decline. You leave the clinic feeling like you have hit a brick wall.
The Specialist Consultation Requirement
The biggest hurdle in the NHS pathway is the "specialist consultation requirement." Unlike a routine medication that your GP can manage, cannabis products are treated as high-risk, niche, and experimental therapies within the public system.
NHS trusts are under immense pressure to balance budgets and follow strict clinical guidelines. Because the long-term clinical trials for many conditions are still ongoing, many NHS consultants are wary of prescribing something that isn't fully backed by decades of data. They fear the regulatory fallout if a treatment goes wrong. Consequently, "limited NHS access to medical cannabis" has become the default status.
The Rise of Private Clinics and Telehealth Platforms
Because the NHS pathway is so narrow, a private sector has blossomed. If you look online, you will see a surge in private clinics offering video consultations. These telehealth platforms have effectively digitized the specialty access pathway.
These clinics operate differently than the NHS. They focus on conditions like chronic pain, anxiety, and PTSD (Post-Traumatic Stress Disorder), which fall outside the very narrow scope of the current NHS guidelines. But here is the catch: because these services are private, you have to pay for the consultation and the medication out of pocket. This has created a massive "access gap" where those with the money can gain legal access, while those relying solely on the NHS are left with almost zero options.
Feature NHS Pathway Private Telehealth Pathway Availability Extremely restricted Broad (via private prescription) Cost Free (standard prescription fees) High (consultation + product cost) Requirement Severe, treatment-resistant conditions Wide range of persistent health issues Speed Slow (referral loops) Fast (often within days)What is the difference between Medical and Recreational Cannabis?
It is newsroompanama.com vital to be clear: medical cannabis is not the same as recreational use. When we talk about medical cannabis, we are talking about pharmaceutical-grade products. These are cultivated under strict conditions to ensure that the levels of THC (tetrahydrocannabinol) and CBD (cannabidiol) are consistent in every single batch.
Recreational cannabis, often sourced from the illicit market, carries unknown contaminants, inconsistent concentrations, and no oversight. Confusing the two does a disservice to patients who are genuinely seeking a regulated, safe way to manage debilitating symptoms under the supervision of a clinician.
Digital-First Healthcare: The Reality of Video Consultations
The shift toward video consultations has been a game-changer for access, but it hasn't solved the underlying systemic issue. Telehealth platforms allow patients to speak with specialists regardless of geography. This removes the barrier of having to travel long distances, which is helpful for patients with chronic pain or mobility issues.
However, these platforms are businesses. While they provide a service to those who need it, they cannot force the NHS to change its stance. They act as a parallel system, not an extension of the public health offer.
Things patients wish they knew before the first video consult
I’ve interviewed many patients who have transitioned from the NHS to private clinics. If you are considering this route, here is the list of things they wish they knew before hitting "book" on that first video consultation:
- You need a summary of your care records: Don't expect the doctor to know your history. You need to request your "Summary Care Record" from your GP practice ahead of time. "Consultation" does not guarantee a prescription: Just because you pay for the call doesn't mean you will walk away with a script. A reputable clinic will decline if they don't believe it's clinically appropriate for you. Costs go beyond the consultation: The initial video call is just the start. You will have follow-up appointments and monthly medication costs. Ask for a full price breakdown early. It is not a "miracle" fix: If a clinic promises that their product will "cure" your condition instantly, that is a massive red flag. Medical cannabis is about symptom management, not a magic wand. Your GP needs to know: Even if you go private, you should inform your NHS GP. It is essential for your medical records to be accurate and for your GP to be aware of all medications you are taking to avoid drug interactions.
The Bottom Line
So, why is it so hard to get medical cannabis on the NHS? It comes down to a combination of rigid, evidence-based prescribing guidelines, a cautious culture regarding new clinical treatments, and the fact that the 2018 law was never intended to make cannabis a first-line treatment for common complaints.
The "access gap" is real and it is frustrating for thousands of patients. While telehealth platforms have provided a lifeline for some, they remain a private solution to a public-sector problem. If you are struggling, start by requesting your full medical records from your GP and speaking openly with your consultant about your treatment history. The path is narrow, and the process is slow, but understanding the rules is the first step toward getting the care you deserve.
Disclaimer: I am a patient advocate and former NHS admin. This content is for information purposes only and does not constitute medical advice. Always speak with your GP or a qualified medical specialist before making decisions about your health.